Virtu Financial, Inc. (VIRT) Q4 2023 Earnings Call Transcript

Virtu Financial, Inc. (NASDAQ:VIRT) Q4 2023 Earnings Conference Call January 25, 2024 7:30 AM ET

Company Participants

Andrew Smith – Director, Senior Vice President, Head-Investor Relations and Corporate Strategy
Douglas Cifu – Chief Executive Officer
Joseph Molluso – Co-President and Co-Chief Operating Officer
Cindy Lee – Deputy Chief Financial Officer

Conference Call Participants

Ken Worthington – JPMorgan
Patrick Moley – Piper Sandler
Chris Allen – Citi
Dan Fannon – Jefferies
Alex Blostein – Goldman Sachs
Michael Cyprys – Morgan Stanley

Operator

Hello, and welcome to the Virtu Financial 2023 Fourth Quarter Results. My name is Alex, and I'll be coordinating the call today. [Operator Instructions]

I'll now hand it over to your host, Andrew Smith of Invest Relations. Please go ahead.

Andrew Smith

Thank you, Alex, and good morning, everyone. Thank you for joining us. Our fourth quarter results were released this morning and are available on our website. With us today on this morning's call, we have Mr. Douglas Cifu, our Chief Executive Officer; Mr. Joseph Molluso, our Co-President and Co-Chief Operating Officer; and Ms. Cindy Lee, our Deputy Chief Financial Officer. We'll begin with prepared remarks and then take your questions.

First, a few reminders. Today's call may include forward-looking statements, which represent Virtu's current belief regarding future events and are therefore subject to risks, assumptions, and uncertainties, which maybe outside the company's control. Please note that our actual results and financial conditions may differ materially from what is indicated in these forward-looking statements. It is important to note that any forward-looking statements made on this call are based on information presently available to the company and we do not undertake, update, or revise any forward-looking statements as new information becomes available. We refer you to disclaimers in our press release and encourage you to review the description of risk factors contained in our annual report, Form 10-K, and other public